ARTICLE | Clinical News

Aeterna to seek approval of AGHD test next year

October 5, 2010 11:44 PM UTC

Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) said it plans to submit an NDA in 1H11 for Solorel macimorelin ( AEZS-130) after reporting interim data from a Phase III trial to diagnose adult growth hor...